These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells. Ichihashi N; Kitajima Y Br J Dermatol; 2001 Apr; 144(4):745-50. PubMed ID: 11298532 [TBL] [Abstract][Full Text] [Related]
3. [Study on the relationship between the resistance to MTX and the transport protein superfamily of ATP-binding cassette that induces multiple drug resistance]. Zhang CY; Feng YX; Li P; Fu SB Yi Chuan; 2006 Oct; 28(10):1201-5. PubMed ID: 17035174 [TBL] [Abstract][Full Text] [Related]
4. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel. Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613 [TBL] [Abstract][Full Text] [Related]
5. Membrane transport proteins associated with drug resistance expressed in human melanoma. Schadendorf D; Makki A; Stahr C; van Dyck A; Wanner R; Scheffer GL; Flens MJ; Scheper R; Henz BM Am J Pathol; 1995 Dec; 147(6):1545-52. PubMed ID: 7495278 [TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791 [TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Pérez-Tomás R Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198 [TBL] [Abstract][Full Text] [Related]
8. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer. Kovalev AA; Tsvetaeva DA; Grudinskaja TV Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes. Hauswald S; Duque-Afonso J; Wagner MM; Schertl FM; Lübbert M; Peschel C; Keller U; Licht T Clin Cancer Res; 2009 Jun; 15(11):3705-15. PubMed ID: 19458058 [TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. Drain S; Flannely L; Drake MB; Kettle P; Orr N; Bjourson AJ; Catherwood MA; Alexander HD Leuk Res; 2011 Nov; 35(11):1457-63. PubMed ID: 21705081 [TBL] [Abstract][Full Text] [Related]
11. [Up-to-date approaches to clinical estimate of phenotype of multiple drug resistance associated with function of ABC-transporters in human solid tumors]. Bogush EA; Kirsanov VIu Antibiot Khimioter; 2006; 51(9-10):50-5. PubMed ID: 18030792 [TBL] [Abstract][Full Text] [Related]
12. Marine Natural Products as Models to Circumvent Multidrug Resistance. Long S; Sousa E; Kijjoa A; Pinto MM Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665 [TBL] [Abstract][Full Text] [Related]
13. ABCB8 mediates doxorubicin resistance in melanoma cells by protecting the mitochondrial genome. Elliott AM; Al-Hajj MA Mol Cancer Res; 2009 Jan; 7(1):79-87. PubMed ID: 19147539 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in pharmacogenomics of ABC transporters involved in breast cancer therapy. Ishikawa T Pharmacogenomics; 2012 Apr; 13(6):633-6. PubMed ID: 22515603 [No Abstract] [Full Text] [Related]
15. Selection and characterization of a high-activity ribozyme directed against the antineoplastic drug resistance-associated ABC transporter BCRP/MXR/ABCG2. Kowalski P; Wichert A; Holm PS; Dietel M; Lage H Cancer Gene Ther; 2001 Mar; 8(3):185-92. PubMed ID: 11332989 [TBL] [Abstract][Full Text] [Related]
16. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506 [TBL] [Abstract][Full Text] [Related]
17. The molecular basis of the chemosensitivity of metastatic cutaneous melanoma to chemotherapy. Parker KA; Glaysher S; Polak M; Gabriel FG; Johnson P; Knight LA; Poole M; Narayanan A; Hurren J; Cree IA J Clin Pathol; 2010 Nov; 63(11):1012-20. PubMed ID: 20924094 [TBL] [Abstract][Full Text] [Related]
18. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547 [TBL] [Abstract][Full Text] [Related]
19. Drug resistance molecules: lessons from oncology. Scheffer GL; Scheper RJ Novartis Found Symp; 2002; 243():19-31; discussion 31-7, 180-5. PubMed ID: 11990777 [TBL] [Abstract][Full Text] [Related]
20. Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. Kuo MT Antioxid Redox Signal; 2009 Jan; 11(1):99-133. PubMed ID: 18699730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]